Abstract:Marfan syndrome (MFS) is a connective tissue disorder that causes complications throughout the body. However, the cardiovascular effects of MFS, specifically aortic aneurysms, are the leading cause of morbidity and mortality in patients. Both the transforming growth factor beta (TGF‐β) and angiotensin II type I receptor (AT1R) signaling pathways are known to contribute to the progression of MFS aneurysms. Recently, our laboratory reported that low‐intensity mild exercise could improve aortic function and structure in the mouse model of MFS. Losartan, an AT1R blocker, has been shown to slow down the progression of MFS aneurysms in both the mouse model and human patients. In this study, we have explored the potential of a combinational therapy of exercise and losartan in a well‐established mouse model of MFS associated aortic aneurysm in order to determine if there are additive protective and delaying effects on the progression of aortic aneurysm in the mouse model. Treatment consisted of 0.6 g/L (full dose) or 0.3 g/L (half dose) of losartan in drinking water combined with a 55% VO 2 max exercise regimen (8 m/min, 30 min/day, 5 days/week). Mice were divided into experimental groups: control, MFS, MFS + exercise, MFS + 0.6 g/L losartan, MFS + 0.3 g/L losartan, MFS + exercise + 0.6 g/L losartan, and MFS + exercise + 0.3 g/L losartan. The biophysical properties of the aorta, such as the aortic diameter and pulse wave velocity (PWV), were determined by high resolution high frequency ultrasound imaging system (Vevo2100, FUJIFILM VisualSonics ) in 3‐month‐old MFS and control mice. Aortic diameter measurements of the sinus of Valsalva were significantly higher in 3‐month‐old MFS mice as compared to control. However, losartan treatment, mild exercise, or combination of both had no effects on aortic root growth in MFS mice. In addition, measurements of the aortic annulus and sinotubular junction were not significantly different among experimental groups. MFS mice exhibited higher PWV as compared to control mice, indicating increased stiffness of aortic wall in these mice. Combination of mild aerobic exercise with full and half dose of losartan seems to have some effects on the aortic wall by decreasing the aortic diameter, although no statistical significant differences were observed among the treated and non‐treated groups. This study presents the effects of combination of mild exercise and losartan during the early stage of aneurysm progression in MFS mice. With the continuation of the longitudinal study at 6 and 9 months of age and as the aneurysm progresses, we will be able to continue our evaluation of aortic and cardiac function and structure in MFS mice subjected to exercise only, losartan only, or the combinational therapy. This study provides additional information on the most effective therapeutic approach to delay the progression of aneurysm in MFS. Support or Funding Information This study is supported by funding from The Marfan Foundation. This abstract is from the Experimental Biology 2018 Meeting. There is no full text article associated with this abstract published in The FASEB Journal .

Investigation of Strategies to Block Downstream Effectors of AT1R-Mediated Signalling to Prevent Aneurysm Formation in Marfan Syndrome

Investigation of early effects of combination of mild aerobic exercise and angiotensin‐II type‐I receptor blocker losartan on aortic function in a mouse model of Marfan Syndrome.

2009 George E. Brown Memorial Lecture—Marfan Syndrome and Related Disorders: From Molecules to Medicines

Dissecting aortic aneurysm in Marfan syndrome is associated with losartan-sensitive transcriptomic modulation of aortic cells

Nitro-oleic acid reduces thoracic aortic aneurysm progression in a mouse model of Marfan syndrome

Lineage-Specific Induced Pluripotent Stem Cell-Derived Smooth Muscle Cell Modeling Predicts Integrin Alpha-V Antagonism Reduces Aortic Root Aneurysm Formation in Marfan Syndrome Mice

Effects of resveratrol on aortic growth in patients with Marfan syndrome: a single-arm open-label multicentre trial

Current and future pharmacological treatment strategies with regard to aortic disease in Marfan syndrome

Complement C3a/C3aR inhibition alleviates the formation of aortic aneurysm in Marfan syndrome mice

An exploration of alternative therapeutic targets for aortic disease in Marfan syndrome

Impact of Notch3 Activation on Aortic Aneurysm Development in Marfan Syndrome

Oral low-dose rapamycin treatment prevents aortic aneurysms in marfan mice

Proteomics analysis on aortic smooth muscle cells reveals new potential targets for the treatment of Marfan syndrome-associated thoracic aortic aneurysm

Single-Cell Transcriptomic Profiling of Vascular Smooth Muscle Cell Phenotype Modulation in Marfan Syndrome Aortic Aneurysm

Methotrexate associated with a lipid core nanoparticle prevented the dilation and dissection of the aortic arch in mice with Marfan syndrome

Abnormal Cardiac Magnetic Resonance–Derived Ascending Aortic Area Strain Demonstrates Altered Ventriculo-Vascular Function in Marfan Syndrome

Versican accumulation drives Nos2 induction and aortic disease in Marfan syndrome via Akt activation

Regnase-1 overexpression as a therapeutic approach of Marfan syndrome

Genetic Manipulation of Caveolin-1 in the Mouse Model of Marfan Syndrome Associated Aortic Root Aneurysm: Effects on Endothelial and Smooth Muscle Function

Allopurinol blocks aortic aneurysm in a mouse model of Marfan syndrome via reducing aortic oxidative stress

Abstract 5314: A Critical Role for TGF- Β Activity in the Protection Against Aortic Aneurysm Formation and Complications in Adult Mice